Technical420 Site Search

Investors, it is time to set aside some cash! On Wednesday, Zynerba Pharmaceuticals, Inc. (ZYNE) will have its initial public offering (IPO) on the NASDAQ exchange. Zynerba will issue 3,000,000 shares and they will be offered in the $13.00-$15.00 range. The total offering amount is $51.75 million (total expenses are…

Yesterday, Zynerba Pharmaceuticals announced the terms of its upcoming initial public offering (IPO). The Pennsylvania-based company plans to raise $42 million by offering 3 million shares in the $13-$15 range. At the midpoint of the proposed range, it would have a fully diluted market value of $128 million. Shares are…

Investors and financial institutions have been patiently waiting for a cannabis-related company to commence trading on a national exchange like the Nasdaq or New York Stock Exchange. Currently, there are only two cannabis related biotech companies that trade on the Nasdaq. These are GW Pharmaceuticals (GWPH) and INSYS Therapeutics, Inc.…

On Tuesday, Heather Alfonso pled guilty in United States District Court in Hartford to having received $83,000 in kickbacks from Insys Therapeutics (INSY) during January 2013 through March 2015. Alfonso said the money influenced her prescribing a particular drug, according to the United States Attorney's Office in Hartford, Connecticut.Although Insys…

Yesterday, Oxis International Inc. (OXIS) filed an information statement stating that its shareholders approved a reverse stock split at a ratio to be decided by the company’s board of directors. The reverse split will not be less than 1-for-50 and it will not be more than 1-for-250. The company’s primary…

The Langone Comprehensive Epilepsy Center at New York University recently conducted a study into a drug that can treat people who suffer from serve forms of epilepsy. The drug is derived from cannabis and contains cannabidiol (CBD). The name of the drug is Epidiolex and it was produced by GW…

Two Nasdaq traded cannabis companies announced earnings during the last week. These companies, Insys Therapeutics (INSY) and GW Pharmaceuticals (GWPH), are focused on improving daily life for millions of people around the world by developing medicines derived from cannabis.Insys Therapeutics, Inc. (INSY)Insys Therapeutics, Inc. is commercial-stage specialty pharmaceutical company that…